z-logo
open-access-imgOpen Access
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
Author(s) -
Gabriella Captur,
James Moon,
ConstantinCristian Topriceanu,
George Joy,
Leo Swadling,
Jenny Hällqvist,
Ivan Doykov,
Nina Patel,
Justyna Śpiewak,
Tomas Baldwin,
Matt Hamblin,
Katia Menacho,
Marianna Fontana,
Thomas A. Treibel,
Charlotte Manisty,
Benjamin O’Brien,
Joseph M. Gibbons,
Corrina Pade,
Tim Brooks,
Daniel M. Altmann,
Rosemary J. Boyton,
Áine McKnight,
Mala K. Maini,
Mahdad Noursadeghi,
Kevin Mills,
Wendy Heywood
Publication year - 2022
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2022.104293
Subject(s) - medicine , asymptomatic , interquartile range , seroconversion , cohort , subclinical infection , immunology , antibody , proteome , young adult , cohort study , bioinformatics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom